Sensitivity of Patient Outcomes to Pharmacist Interventions. Part I: Systematic Review and Meta-Analysis in Diabetes Management

Abstract

Spanish

French

Background:

Pharmacists participate in managing diabetes therapy. Despite many reviews, few have quantified the impact of pharmacists' interventions.

Objectives:

TO identity outcomes sensitive to pharmacists' interventions and quantify their impact through critical literature review.

Methods:

All original research describing the impact of pharmacists' interventions in the management of diabetic pharmacotherapy was sought in International Pharmaceutical Abstracts, MEDLINE, Embase, Cochrane Register, and Cumulative Index to Nursing & Allied Health Literature from inception through 2006. Two independent reviewers identified articles, compared results, and settled differences through consensus. The Downs-Black scale was used to assess quality. Data included intervention type, patient numbers, demographics, study characteristics, instruments used, data compared, and outcomes reported. A random-effects meta-analysis combined amenable results.

Results:

Of 302 articles identified, 108 involved pharmacists' interventions; 36 addressed diabetes (14 medical clinics, 11 community pharmacies, 7 ambulatory care clinics, 4 hospital wards, 1 physician's office, 1 prison, and 3 in both medical clinics and community pharmacies; 1 did not describe its practice site). Research designs included randomized (n = 18) and nonrandomized (n = 9) controlled trials, pre- and postobservational cohorts (n = 2), retrospective cohort study (n = 1), chart reviews (n = 5), and database study (n = 1). Diabetes education (69%) and medication management (61%) were the most frequently used Interventions. Mean ± SD quality was 62 ± 11% (fair). Fifty-one (69%) study results were sensitive, Meta-analysis of data from 2247 patients in 16 studies found a significant reduction in hemoglobin A_1C (A1C) levels in the pharmacists' intervention group (1.00 ± 0.28%; p < 0.001) but not in controls (0.28 ± 0.29%; p = 0.335). Pharmacists' interventions further reduced A1C values 0.62 ± 0.29% (p = 0.03) over controls.

Conclusions:

A1C is sensitive to pharmacists' interventions. Several potentially sensitive outcomes were identified, but too few studies were available for quantitative summaries. More research is needed.

Keywords

diabetes glycemic control glycosylated hemoglobin pharmacist intervention

Get full access to this article

View all access options for this article.

References

Amos

, McCarthy

, Zimmet

. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997;14(suppl):S1–85.

World Health Organization. Diabetes programme, www.who.int/diabetes/eng (accessed 2006 Sept 29).

Klein

, Klein

BEK

. Vision disorders in diabetes. In: National Diabetes Data Group, eds. Diabetes in America. 2nd ed. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995:293–338. NIH Publication no. 95–1468.

Nelson

, Knowler

, Pettit

. Kidney diseases in diabetes. In: National Diabetes Data Group, eds. Diabetes in America. 2nd ed. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995:349–400. NIH Publication no. 95–1468.

Johnson

. Self-efficacy theory as a framework for community pharmacy-based diabetes education programs. Diabetes Educ 1996;22:237–41.

The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–86.

Shojania

, Ranji

, McDonald

, Grimshaw

, Rushakoff

, Owens

. Effects of quality improvement strategies for type 2 diabetes on glycemic control. JAMA 2006;296:427–40.

Hepler

, Strand

Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533–43.

Strand

Re-visioning the profession. J Am Pharm Assoc 1997;37:474–8.

10.

Glazier

, Bajcar

, Kennie

, Willson

A systematic review of interventions to improve diabetes care in socially disadvantaged populations. Diabetes Care 2006;29:1675–88.

11.

Downs

, Black

The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Commun Health 1998;52:377–84.

12.

Begg

, Mazumdar

Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088–101.

13.

Cochran

. The combination of estimates from different experiments. Biometrics 1954;10:101–29.

14.

Armour

, Taylor

, Hourihan

, Smith

, Krass

Implementation and evaluation of Australian pharmacists' diabetes care services. J Am Pharm Assoc 2004;44:455–66.

15.

Berringer

, Shibley

MCH

, Cary

, Pugh

, Powers

PAG

, Rafi

. Outcomes of a community pharmacy-based diabetes monitoring program. J Am Pharm Assoc 1999;39:791–7.

16.

Choe

, Mitrovich

, Duaby

, Hayward

, Krein

, Vijan

Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized clinical trial. Am J Manag Care 2005;11:253–60.

17.

Cioffi

, Caron

, Kalus

, Hill

, Buckley

. Glycosylated hemoglobin, cardiovascular, and renal outcomes in a pharmacist-managed clinic. Ann Pharmacother 2004;38:771–5. DOI 10.1345/aph.1D359

18.

Clifford

, Batty

, Davis

TME

, . A randomised controlled trial of a pharmaceutical care programme in high-risk diabetic patients in an outpatient clinic. Int J Pharm Pract 2002;10:85–9.

19.

Clifford

, Davis

, Batty

, Davis

TME

. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes. Diabetes Care 2005;28:771–6.

20.

Coast-Senior

, Kroner

, Kelley

, Trilli

. Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother 1998;32:636–41. DOI 10.1345/aph.17095

21.

Cranor

, Bunting

, Christensen

. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 2003;43:173–84.

22.

Davidson

, Karlan

, Hair

. Effect of a pharmacist-managed diabetes care program in a free medical clinic. Am J Med Qual 2000;15:137–42.

23.

Garret

, Blumi

. Patient self-management program for diabetes: first-year clinical, humanistic, and economic outcomes. J Am Pharm Assoc 2005;45:130–7.

24.

Gong

, Hasson

, Lum

. Impact of a diabetes disease management clinic in the total glycosylated hemoglobin of patients with type 2 diabetes mellitus. J Managed Care Pharm 1999;5:511–5.

25.

Hawkins

, Fiedler

, Douglas

, Eschbach

. Evaluation of a clinical pharmacist in caring for hypertensive and diabetic patients. Am J Hosp Pharm 1979;36:1321–5.

26.

Hirsh

, Goldberg

, Ellsworth

, . A multifaceted intervention in support of diabetes treatment guidelines: a controlled trial. Diabetes Res Clin Pract 2002;58:27–36.

27.

Irons

, Lenz

, Anderson

, Wharton

, Habeger

, Anderson

A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic. Pharmacotherapy 2002;22:1294–300.

28.

Jaber

, Halapy

, Fernet

, Tummalapalli

, Diwakaran

Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother 1996;30:238–43.

29.

Kelly

, Rodgers

. Implementation and evaluation of a pharmacist-managed diabetes service. J Manag Care Pharm 2000;6:488–93.

30.

Kiel

, McCord

. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother 2005;39:1828–32. Epub 11 Oct 2005. DOI 10.1345/aph.1G356

31.

Krass

, Taylor

, Smith

, Armour

. Impact on medication use and adherence of Australian pharmacists' diabetes care services. J Am Pharm Assoc 2005;45:33–40.

32.

McCord

. Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service. Pharmacotherapy 2006;26:248–53.

33.

Morello

, Zadvorny

, Cording

, Suemoto

, Skog

, Harari

Development and clinical outcomes of pharmacist-managed diabetes care clinics. Am J Health Syst Pharm 2006;63:1325–31.

34.

Odegard

, Goo

, Hummel

, Williams

, Gray

. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother 2005;39:433–40. Epub 8 Feb 2005. DOI 10.1345/aph.1E438

35.

Ragucci

, Fermo

, Wessell

, Chumney

ECG

. Effectiveness of pharmacist-administered diabetes mellitus education and management services. Pharmacotherapy 2005;25:1809–16.

36.

Raji

, Gomes

, Beard

, MacDonald

, Conlin

. A randomized trial comparing intensive and passive education in patients with diabetes mellitus. Arch Intern Med 2002;162:1301–4.

37.

Rothman

, Malone

, Bryant

, Horlen

, Pignone

Pharmacist-led, primary care-based disease management improves hemoglobin Ale in high-risk patients with diabetes. Am J Med Qual 2003;18:51–8.

38.

Rothman

, Malone

, Bryant

, Horlen

, Dewalt

, Pignone

The relatonship between literacy and glycemic control in a diabetes disease-management program. Diabetes Educ 2004;30:263–73.

39.

Rothman

, Malone

, Bryant

, . A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am J Med 2005;118:276–84.

40.

Sadur

, Moline

, Costa

, . Diabetes management in a health maintenance organization. Diabetes Care 1999;22:2011–7.

41.

Sarkadi

, Rosenqvist

Experience-based group education in type-2 diabetes: a randomised controlled trial. Patient Educ Couns 2004;53:291–8.

42.

Sczupak

, Conrad

. Relationship between patient-oriented pharmaceutical services and therapeutic outcomes of ambulatory patients with diabetes mellitus. Am J Hosp Pharm 1977;34:1238–42.

43.

Shane-McWhorther

, Oderda

. Providing diabetes education and care to underserved patients in a collaborative practice at a Utah community health center. Pharmacotherapy 2005;25:96–109.

44.

Simpson

, Johnson

, Biggs

, Tsuyuki

. Greater effect of enhanced pharmacist care on cholesterol management in patients with diabetes mellitus: a planned subgroup analysis of the study of cardiovascular risk intervention by pharmacists (SCRIP). Pharmacotherapy 2004;24: 389–94.

45.

Suppapitiporn

, Chindavijak

, Onsanit

Effect on diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial. J Med Assoc Thai 2005;88(suppl):S134–41.

46.

Taylor

, Byrd

, Krueger

Improving primary care in rural Alabama with a pharmacy initiative. Am J Health Syst Pharm 2003;60:1123–9.

47.

Taylor

, Milanova

, Hourihan

, Krass

, Coleman

, Armour

. A cost-effectiveness analysis of a community pharmacist-initiated disease state management service for type 2 diabetes mellitus. Int J Pharm Pract 2005;13:33–40.

48.

Veldhuizen-Scott

MKV

, Widmer

, Stacey

, Popovich

. Developing and implementing a pharmaceutical care model in an ambulatory care setting for patients with diabetes. Diabetes Educ 1995;21:117–23.

49.

Wermeille

, Bennie

, Brown

, McKnight

Pharmaceutical care model for patients with type 2 diabetes: integration of the community pharmacist into the diabetes team—a pilot study. Pharm World Sci 2004; 26:18–25.

50.

Johnson

, Guirguis

. Diabetes: are pharmacists making an impact on patient outcomes? CPJ 2003;136:24–8.

51.

Van Wijk

BLG

, Klungel

, Heerdink

, de Boer

Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review. Ann Pharmacother 2005;39:319–28. Epub 4 Jan 2005. DOI 10.1345/aph.1E027